Zoledronic Acid in Acute Spinal Cord Injury

PHASE3CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Spinal Cord Injury
Interventions
DRUG

Zoledronic acid

5 mg zoledronic acid infused intravenously over two hours (2.5mg per hour), given only once, within 21 days of acute traumatic spinal cord injury.

DRUG

normal saline 0.9%

Infusion of equivalent volume of 0.9% normal saline to that of the reconstituted zoledronic acid, given only once over two hours, occurring within 21 days of acute traumatic spinal cord injury

Trial Locations (1)

19107

Thomas Jefferson University and Hospital, Philadelphia

All Listed Sponsors
collaborator

Department of Health and Human Services

FED

lead

Thomas Jefferson University

OTHER

NCT01642901 - Zoledronic Acid in Acute Spinal Cord Injury | Biotech Hunter | Biotech Hunter